Drug Shortage Report for MINT-LACOSAMIDE

Last updated on 2021-02-23 History
Report ID 131336
Drug Identification Number 02490544
Brand name MINT-LACOSAMIDE
Common or Proper name Lacosaminde
Company Name MINT PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) LACOSAMIDE
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 60 count bottles
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2021-01-11
Estimated end date
Actual end date 2021-02-10
Shortage status Resolved
Updated date 2021-02-23
Company comments
Health Canada comments
Contact Address 6575 DAVAND DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 2M3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-02-23 French Compare
v4 2021-02-23 English Compare
v3 2021-01-12 English Compare
v2 2021-01-11 French Compare
v1 2021-01-11 English Compare